We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




European Genomic Resource Center to Offer High-Throughput Gene Expression Profiling

By LabMedica International staff writers
Posted on 08 Mar 2012
A major European provider of genomic research and training services has announced a major expansion into the area of high-throughput gene expression profiling.

TATAA Biocenter (Gothenburg, Sweden) has established a reputation as one of Europe´s leading providers of genomic services using quantitative real-time polymerase PCR (qPCR). More...
Real-time PCR is a modification of standard PCR and provides greater accuracy in applications such as the quantification of gene expression, proteins, viruses, and bacteria in human, food, and soil samples, and for analysis of mutations (SNP), detection of gene-modified organisms (GMO), and forensic testing. The process involves cycles of alternative heating and cooling of a small sample containing the nucleic acid. Throughout this process, copies of targeted DNA molecules are produced and the amount of the amplified DNA is measured during the PCR process in real-time. This ensures very accurate and precise quantification of the nucleic acid.

Adding to its catalog of research and training options, TATAA Biocenter has recently announced the introduction of high-throughput gene expression profiling using Roche´s (Basel, Switzerland) RealTime Ready Custom qPCR Assays and Panels. An example is the LightCycler 1536 System, which utilizes a proprietary 1536-well plate and is capable of performing high-speed, qPCR-based DNA/RNA analyses in an array-like format.

“The number of genes researchers characterize in a given sample is steadily increasing. In response to this demand, we now offer high-throughput profiling services in a complete workflow from nucleic acid extraction, gene profiling, and data mining,” said Dr. Mikael Kubista, CEO of TATAA Biocenter. “After extensive testing and validation of the various offerings on the market, we selected the Roche RealTime Ready platform for its excellent performance combined with a workflow with exceedingly user-friendly wizard-based data mining.”

Related Links:
TATAA Biocenter


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.